ADP Insider DeSilva Sells 5,909 Shares; 10b5-1 Plan Disclosed
Rhea-AI Filing Summary
Joseph DeSilva, Executive Vice President of Automatic Data Processing, reported several insider transactions on Form 4. On 09/01/2025 he was credited with 3,879 restricted stock units that convert one-for-one to common shares and vest ratably over three years, bringing his indicated holdings to 28,059.032 shares. On 09/02/2025 he exercised a stock option for 1,987 shares at a $206.86 exercise price under an option grant exercisable since 09/01/2022 (expiring 08/31/2031), then sold 1,987 shares at $301.64. The filing also shows a disposition of 5,909.418 shares at $304.05, leaving reported beneficial ownership of 22,149.614 shares after the transactions. Reported trades on 09/02/2025 were executed pursuant to a Rule 10b5-1 trading plan adopted September 2024.
Positive
- Transactions disclosed under a Rule 10b5-1 trading plan, indicating pre-established trade instructions
- RSU vesting schedule provided (3,879 RSUs vest ratably over three years), improving transparency
- Option exercise and sales fully reported with prices, showing clear execution and proceeds information
Negative
- Significant reduction in reported beneficial ownership from 30,046.032 to 22,149.614 shares after sales
- Large cash-outs via sales (5,909.418 shares at $304.05) may be viewed unfavorably by some investors seeking insider accumulation
Insights
TL;DR: Insider exercised options and sold shares under a pre-established 10b5-1 plan; holdings declined after sell transactions.
DeSilva exercised a 1,987-share option at $206.86 and sold those 1,987 shares at $301.64, realizing an immediate spread between exercise and sale prices. Additional dispositions of 5,909.418 shares at $304.05 materially reduced his reported beneficial ownership from 30,046.032 to 22,149.614 shares. The filing explicitly states the trades on 09/02/2025 were effected under a Rule 10b5-1 plan adopted in September 2024, which indicates pre-planned timing rather than ad hoc selling. For investors, these are routine executive liquidity events rather than operational disclosures; no new financial results or corporate actions are reported.
TL;DR: Transactions are documented and tied to a 10b5-1 plan; RSU vesting schedule is disclosed.
The Form 4 properly discloses acquisitions and dispositions and notes that 3,879 restricted stock units convert one-for-one and vest ratably over three years. Use of a 10b5-1 trading plan, identified in the filing, supports an affirmative defense to insider trading claims. The sequence—vesting/acquisition, option exercise, and subsequent sales—aligns with common executive compensation and tax-cover practices. From a governance standpoint, disclosures are complete and consistent with Section 16 reporting requirements.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 1,987 | $206.86 | $411K |
| Exercise | Common Stock | 1,987 | $206.86 | $411K |
| Sale | Common Stock | 1,987 | $301.64 | $599K |
| Tax Withholding | Common Stock | 5,909.418 | $304.05 | $1.80M |
| Grant/Award | Common Stock | 3,879 | $0.00 | -- |
Footnotes (1)
- In the form of restricted stock units, which are convertible into common stock on a one-for-one basis and vest ratably over 3 years. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in September 2024.